Literature DB >> 26384067

Urothelial carcinoma arising from an ovarian mature cystic teratoma.

Hui-Yu Chuang1, Yi-Ting Chen2, Tak-Loi Mac1, Yu-Chieh Chen1, Hung-Sheng Chen1, Wan-Shan Wang3, Eing-Mei Tsai4.   

Abstract

OBJECTIVE: Ovarian mature cystic teratomas with malignant transformation are rare, and squamous cell carcinoma is the most common pathological entity. Among these malignant transformations, urothelial cell carcinoma is rare. CASE REPORT: We report a woman presenting with a huge pelvic cystic mass, favoring a right ovarian mature cystic teratoma with malignant transformation, based on magnetic resonance imaging, who was successfully treated with surgery.
CONCLUSION: The final pathology confirmed concomitant malignant transformation of urothelial carcinoma.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  malignant transformation; teratoma; urothelial carcinoma

Mesh：

Year:  2015        PMID： 26384067     DOI： 10.1016/j.tjog.2015.06.003

Source DB:  PubMed          Journal:  Taiwan J Obstet Gynecol        ISSN： 1028-4559            Impact factor:   1.705


  3 in total

1.  A Rare Malignant Transformation of an Ovarian Cystic Teratoma: A Case Report.

Authors:  Manju Rachel Mathew; Anita Ramdas; Susy S Kurian; Linu Kuruvilla; Neelima Singh
Journal:  Case Rep Pathol       Date:  2018-07-09

2.  A case of ovarian clear cell carcinoma arising from ovarian mature cystic teratoma.

Authors:  Kazuya Maeda; Yoshito Terai; Shinichi Terada; Hiroshi Maruoka; Yuhei Kogata; Keisuke Ashihara; Yoshimichi Tanaka; Tomohito Tanaka; Hiroshi Sasaki; Satoshi Tsunetoh; Takashi Yamada; Masahide Ohmichi
Journal:  J Ovarian Res       Date:  2018-08-30       Impact factor: 4.234

3.  Rare occurrence of pseudomyxoma peritonei (PMP) syndrome arising from a malignant transformed ovarian primary mature cystic teratoma treated by cytoreductive surgery and HIPEC: a case report.

Authors:  Francesca Ponzini; Luke Kowal; Mariam Ghafoor; Allison Goldberg; Joanna Chan; Ryan Lamm; Shawnna M Cannaday; Scott D Richard; Avinoam Nevler; Harish Lavu; Wilbur B Bowne; Norman G Rosenblum
Journal:  World J Surg Oncol       Date:  2022-03-11       Impact factor: 2.754
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.